JESSICA FUENTES: Open Payments
NPI 1508396755 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 23 payments from 10 companies in 2025. Trend: 2023 $695 · 2024 $619 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $153 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Janssen Biotech, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $45 |
| ABBVIE INC. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $28 |
| TOLMAR, INC. | 1 | $26 |
| Endo USA, Inc. | 1 | $18 |
| 180 Medical, Inc. | 1 | $14 |
Products named: XTANDI, LYNPARZA, ERLEADA, ORGOVYX, PROLARIS, JATENZO, KEYTRUDA QLEX, LUPRON DEPOT.
Industry payments across GA — which companies pay providers there.
